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Abstract: Several bioactive compounds are in use for the treatment of neurodegenerative disorders,
such as Alzheimer’s and Parkinson’s disease. Historically, willow (salix sp.) bark has been an
important source of salisylic acid and other natural compounds with anti-inflammatory, antipyretic
and analgesic properties. Among these, picein isolated from hot water extract of willow bark,
has been found to act as a natural secondary metabolite antioxidant. The aim of this study was to
investigate the unrevealed pharmacological action of picein. In silico studies were utilized to direct
the investigation towards the neuroprotection abilities of picein. Our in vitro studies demonstrate the
neuroprotective properties of picein by blocking the oxidative stress effects, induced by free radical
generator 2-methyl-1,4-naphthoquinone (menadione, MQ), in neuroblastoma SH-SY5Y cells. Several
oxidative stress-related parameters were evaluated to measure the protection for mitochondrial
integrity, such as mitochondrial superoxide production, mitochondrial activity (MTT), reactive
oxygen species (ROS) and live-cell imaging. A significant increase in the ROS level and mitochondrial
superoxide production were measured after MQ treatment, however, a subsequent treatment with
picein was able to mitigate this effect by decreasing their levels. Additionally, the mitochondrial
activity was significantly decreased by MQ exposure, but a follow-up treatment with picein recovered
the normal metabolic activity. In conclusion, the presented results demonstrate that picein can
significantly reduce the level of MQ-induced oxidative stress on mitochondria, and thereby plays a
role as a potent neuroprotectant.
Keywords: menadione; picein; ROS; MitoSOX; live cell imaging; oxidative stress; neuroblastoma
SH-SY5Y cells; neurodegenerative disorder
1. Introduction
In recent years, the growing percentage of neurodegenerative diseases has been attributed to an
induced oxidative stress array of human health, environment, and lifestyle factors [1,2]. It is known that
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the physiology of neurodegenerative diseases is multifactorial, and several recent studies confirm that
potential superficial factors like radiation [3,4] or chemical compound exposures [5–7] are associated
with the risk of the onset of neuronal diseases. Exogenous compounds such as menadione (MQ)
(2-methyl-1,4-naphthoquinone), offer an examination of the oxidative stress-induced cytotoxicity in the
cell, where due to the formation of reactive oxygen species (ROS), the cell either becomes dysfunctional
or dies (Figure 1) [8,9]. Such a situation may occur if the ROS formation exceeds the scavenging
capacity of the antioxidants. The cytotoxic effect of menadione-induced oxidative stress may occur
in distinct redox states and its cycling may generate ROS in target cells [10], which may cause cell
injury and result in the pathogenesis of various neurodegenerative disorders, for example Parkinson’s
disease (PD) [11] and most commonly Alzheimer’s disease (AD) [12–15]. According to the World
Alzheimer report, 46.8 million people worldwide are living with dementia in 2015 [16]. Alarmingly,
this forecasted number could double or triple after every 20 years through to the year 2040, which
would lead to an expensive burden of disease on society in the future [16,17].
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Figure 1. An overview of the experimental plan representing (a) the isolation of picein from willow 
bark [18] followed by its (b) in silico and (c) in vitro studies. In silico studies for the identification of 
putative biomolecular target reveals Beta Secretase 1 (BACE-1) as the highest-ranked target enzyme 
for picein, which might indicate its neuroprotective role. Amyloid precursor protein (APP) is a 
prerequisite for β-amyloid (Aβ) formation, which is sequentially cleaved by BACE1. In vitro studies 
on SHSY5Y cells shows that menadione induces mitochondrial ROS, superoxide production and also 
mitochondrial depolarization which lead to mitochondrial damage and ultimately apoptosis of the 
cell. Furthermore, subsequent treatment with picein recovers the mitochondrial function through its 
antioxidative effects and thus plays an important role in neuroprotection. 
Continuing efforts through the years have been made to find an antioxidant that can lower the 
accelerating aging of neurons due to oxidative damage leading to neurodegenerative diseases, also 
reported by Poljsak and Milisav [19]. Therefore, this study aimed to explore the neuroblastoma SH-
SY5Y cell type-specific responses to menadione-induced oxidative stress and repair mechanisms by 
using the authentic compound ‘picein’ that is also present in willow bark water extracts [16]. Willow 
Figure 1. An overview of the experimental plan representing (a) the isolation of picein from willow
bark [18] followed by its (b) in silico and (c) in vitro studies. In silico studies for the identification of
putative biomolecular target reveals Beta Secretase 1 (BACE-1) as the highest-ranked target enzyme for
picein, which might indicate its neuroprotective role. Amyloid precursor protein (APP) is a prerequisite
for β-amyloid (Aβ) formation, which is sequentially cleaved by BACE1. In vitro studies on SHSY5Y
cells shows that menadione induces mitochondrial ROS, superoxide production and also mitochondrial
depolarization which lead to mitochondrial damage and ultimately apoptosis of the cell. Furthermore,
subsequent treatm nt with picein recovers the mitochondrial function through its antioxidative effects
and thus plays an important role in neuroprotection.
Continu efforts through th years have been made to fi d an antioxidant th t can lower
the accelerating aging of neurons due to oxidative damage lea ing to n urod generative diseases,
also reported by Poljsak and Milisav [19]. Therefore, this study aimed to explore the neuroblastoma
SH-SY5Y cell type-specific responses to menadione-induced oxidative stress and repair mechanisms by
using the authentic compound ‘picein’ that is also present in willow bark water extracts [16]. Willow
bark extracts are known as a rich source of antioxidants and have significant potential for medical
applications [20–22]. Willow bark has shown importance in the past with the discovery of aspirin
(acetylsalicylic acid) for the treatment of anti-inflammatory, antipyretic and analgesic conditions [23].
Recently from our group, Dou et al. [18] demonstrated a cost-effective and efficient method for extracting
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the bioactive compounds picein, triandrin and catechin from the bark of salix hybrid Karin. In this
study, a bioinformatics approach was first applied on extracted compounds reported by Dou et al. [18]
and thereafter picein was opted for use in in vitro studies due to its strong role in the treatment of AD.
In vitro studies were performed on SH-SY5Y neuroblastoma cells because of their close resemblance to
neurons and they are accepted as a unique model for neurodegenerative diseases [24–26].
For the measurements of oxidative stress, we examined the cellular changes induced by MQ
(highly responsible for causing DNA damage and ROS production) at several concentrations followed
by the neuroprotectant picein (antioxidant) in menadione-treated neuroblastoma cells. To confirm
the role of menadione and picein, live-cell imaging was assessed as a measure of mitochondrial
dysfunction. Mitochondrial superoxide and ROS production were measured as indicators of oxidative
stress along with mitochondrial activity using thiazolyl blue tetrazolium bromide (MTT). The rationale
for measuring these endpoints was to establish a link between neurodegeneration and AD. Although,
several researchers have reported that oxidative stress-induced ROS formation may be the link to human
health, and leads to pathological diseases, which has been found as a leading cause of death [27–29].
Our hypothesis is based on the qualitative and functional similarity of picein (as one of the
Karin bark water extract’s component), to that of the bioactive compound, ‘gastrodin’ extracted
from the dried rhizome of Gastrodia elata. Gastrodin is a well-known phenolic glycoside, which
possess neuropharmacological properties such as anti-inflammatory, antioxidative, and modulating
the secretion of neurotransmitters that suppresses the activation of microglia and regulates the
mitochondrial cascade reactions like mitochondrial durability and functionality [30]. Many researchers
have reported a significant role of gastrodin in neurological diseases such as AD [31–33], PD [34–36],
and depression [37,38]. Structurally, picein showed a 92% similarity score with gastrodin. In this
consideration, we performed in silico and in vitro studies to explore the scavenging capacity of picein
against menadione. This is the first report to our knowledge showing the potential role of picein
as neuroprotectant which attenuates the cytotoxic effect of menadione-induced oxidative stress in
neurodegenerative diseases.
2. Materials and Methods
2.1. Chemical Similarity Search
SIMCOMP (SIMilar COMPound), a plug-in of the Kyoto Encyclopedia of Genes and Genomes
(KEGG) database, was used for the chemical structure similarity search. This software was used for the
selection and identification of similar or identical chemical structures to predict the analog of the query
compound on the basis of a graph-based method [39]. Similarity search is an important parameter to
reach any certain prediction as we can see in the present study of picein and gastrodin [39].
2.2. Testing of Lipinski’s Rule of 5, Generation of 3D Model of Protein and Ligands and Docking Studies
The chemical descriptor and drug-like properties of picein (PubChem ID: 92123) and gastrodin
(PubChem ID: 115067) were observed by using Lipinski’s rule of 5 (www.molinspiration.com),
where this rule was specially designated for the selection of small druggable compounds [40,41].
Conical SMILE IDs is a specific and particular chemical structure characteristic of every chemical
compound which is usually mentioned in chemical databases. PubChem database, CORINA 3D
server is an important software which converts the SMILE ID into a three-dimensional .pdb structure.
The RCSB protein data bank (Research Collaboratory for Structural Bioinformatics protein data bank)
was used for procuring the 3D structure of amyloid beta-peptide (PDB ID: 1IYT). Auto Dock Tool 4
(MGL Tool: Molecular graphics laboratory) is a globally accepted docking tool, which was used in this
study to identify the poses of ligands, proteins and the binding affinities [42].
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2.3. Identification of Putative Biomolecular Target and Protein-Protein Interaction Analysis
A reverse docking (PharmMapper Server) approach was used to identify the putative targets of
picein and gastrodin. This web-server identifies the most probable target candidates of small-scale
molecules on the basis of a pharmacophore mapping approach. Protein-protein interactions and
topological analysis were performed using a CHIPPI (CHimeric protein-protein interaction server)
web-server [43].
2.4. Mammalian Cell Culture
For the experiments, human SH-SY5Y neuroblastoma cells (collected from Dr. Juan Cruz Landoni,
Research Program for Molecular Neurology, University of Helsinki) were obtained and grown in
Dulbecco’s modified Eaglés medium (DMEM). For cell culture, 10% foetal bovine serum (FBS) along
with a mixture of streptomycin (50 µg/mL)/penicillin (50 U/mL) was added in DMEM (4.5 g/L glucose).
The SH-SY5Y cell cultures were grown and maintained in Eppendorf cell culture flasks (T-75, Catalogue
0030711025) at 37 ◦C in a humidified incubator with supply of 5% CO2. For experimental assays, cells
were trypsinized by 0.2% trypsin and seeded at a density of 2 × 105 cells in 48-well plates (Costar,
Corning, NY, USA).
2.5. Experimental Design for In Vitro Studies
Experiments were conducted to confirm the neuroprotectant role of picein in a changing level
of mitochondrial superoxide and ROS production by suppressing the effect of MQ. Menadione was
used to induce oxidative stress and cause ROS formation in the cells. Picein (74192) and menadione
(MQ) (M5625) were purchased from Sigma Aldrich, USA. For the experiments, the following treatment
groups were taken—(1) control, (2) Picein (3) MQ, (4) MQ + Picein. Induction of oxidative stress
involves the incubation of cells with MQ for 2 h with the subsequent treatment with picein for 2.5 h.
The MQ concentrations were 0, 1, 10, 15 and 20 µM and the picein concentration was fixed at 25 µM.
Dose-response experiments were employed for the standardization of picein concentration, where
concentrations of 1, 10, 15, 25, 50, and 100 µM were used to obtain the higher cell survival rate
(data not presented). We obtained the best cell survival rate at 25 µM of picein, although 20 µM was
the maximum dose for menadione recorded. Commercially available authentic picein (≥98.0% HPLC
grade) was used for the treatment of menadione-stressed neuroblastoma cells during the present study.
Live cell imaging, ROS, mitochondrial superoxide, and mitochondrial activity (MTT), were performed
immediately after the picein treatment. A blank (without cells) was involved in the assay for the
measurements, where the absolute values were subtracted from the blank value.
2.6. Mitochondrial Activity (MTT) Assay
Mitochondrial activity was measured using 3-(4,5-dimethylthiazol-2-thiazolyl)-2,5 diphenyl
tetrazolium bromide or thiazolyl blue tetrazolium bromide (MTT; Sigma Aldrich, Saint Louis, MO 63103,
USA). Immediately after the menadione and picein treatment, the medium was removed from the
48-well plates and replaced with the assay-specific probe in 250 µL complete media containing
25 µL MTT solution (5 mg/mL) and kept for 3 h of incubation in the incubator. After incubation to
dissolve formazan crystals, MTT solution was replaced with 250 µL DMSO in each well. The reading
of absorbance was taken with a microplate reader at a wavelength of 550 nm (Cytation 3, BioTek
Instruments, Inc., Winooski, VT, USA).
2.7. Reactive Oxygen Species (ROS) Formation
ROS production was assayed using 2′,7′-dichlorofluorescein diacetate (DCFH-DA) from a
Sigma-Aldrich (St. Louis, MO, USA) assay-specific probe. Immediately after the menadione and picein
treatment, the medium was removed from the 48-well plates and replaced with the assay-specific probe
DCF-DA (40 µM) in 0.5 mL of Hank’s balanced salt solution and thereafter incubated for 30 min in the
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incubator. Further, fluorescence was measured at 485 nm excitation/535 nm emission wavelengths by a
Biotek Cytation Reader 3 (BioTek Instruments, Inc., Winooski, VT, USA).
2.8. Mitochondrial Superoxide Production
Mitochondrial superoxide production was analyzed as described previously [44]. A fluorescent
probe, MitoSOX red (3,8-phenanthridinediamine, 5-(6′-triphenylphosphoniumhexyl)-5,6-dihydro-
6-phenyl) (M36008) was purchased from Molecular Probes (Thermo Fisher Scientific, 29851 Willow
Creek Road, Eugene, OR 97402, USA). Briefly, for the analysis of mitochondrial superoxide production,
MitoSOX red with a final concentration of 4µM was added in phosphate buffer saline (PBS). Immediately
after picein treatment, the medium was removed and washed with PBS and thereafter, the assay-specific
probe in 0.5 mL of buffer for 15 min incubated in the incubator at 37 ◦C. After incubation, the probe
was replaced with warm buffer, and fluorescence intensity was measured at 510 nm excitation/640 nm
emission wavelengths by a Biotek Cytation Reader 3 (BioTek Instruments, Inc., Winooski, VT, USA).
2.9. Live Cell Imaging
The SH-SY5Y neuroblastoma cells were allowed to attach at the glass-bottom well plates by
following all the treatment processes. Thereafter, the cells were washed thrice with serum-free DMEM
and 0.2 uL of Mitotracker orange (MitoTracker®, Thermo Fisher Scientific, Eugene, OR, USA) was
added first to 1.5 mL of medium and then poured drop by drop to the dish. Cells were incubated
at 37 ◦C with a supply of 5% CO2 for 30 min and further maintained at similar conditions during
the imaging. The live-cell imaging was performed with a confocal microscope (Leica TCS SP5, Leica
Microsystems, Am Friedensplatz 3. 68165 Mannheim, Germany) and images were obtained by using a
63X water objective. The Mitotracker orange was excited by a 561 nm diode laser. The fluorescence
signal was collected at 575–610 nm with PMTs (Photomultiplier tubes) for Mitotracker orange.
2.10. Statistical Analysis
For the statistical analysis, a general liner model procedure of SPSS was carried out to see the
statistically significant differences between groups. In this process, factorial ANOVA (in factorial
design) was applied, where MQ and picein were allocated as fixed factors and in the same model
replicate as random factors. Also, to check the significant differences within groups, a paired t-test was
applied. A difference in p-value less than 0.05 was reported statistically significant.
3. Results
3.1. Chemical Similarity Search
SIMCOMP (SIMilar COMPound), a plug-in of KEGG database system, was used for the
identification of similar compound properties like picein. On the basis of a graph-based method of
this database, gastrodin was found to have a similarity score of 0.92 (gastrodin shares 92% chemical
structure similarity with Picein) out of 1, and spotted to have the highest analogy or similarity with
picein (Table 1). This shows that picein and gastrodin are similar in chemical structure, and this
supports the characteristics of bioactive compounds for disease treatment.
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Table 1. SIMCOMP (SIMilar COMPound) similarity score of picein and gastrodin.
S. No. Chemical Name Chemical Structure Similarity Score
1 Picein
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normalized fit score: 0.2157, Z-Score: 0.896571). After screening both of compounds, Beta Secretase 1
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potential role in the pathogenies of neurodegenerative diseases has also been reported.
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3.3. Testing of Lipinski’s Rule of 5 and Docking Analysis
This study was focused on identifying the chemical descriptors along with druglike and molecular
binding properties of picein and gastrodin. The notation for picein and gastrodin were LogP −0.43 and
−0.99, topological polar surface area 116.45 and 119.61, molecular weight 298.29 and 286.28 gmol−1,
the total number of hydrogen bond acceptors seven and seven, hydrogen donors five and four, and the
total number of rotatable bonds were four and four, respectively. Thus, neither picein nor gastrodin
has been observed to violate any rule of Lipinski’s. The binding affinities and Ki value (dissociation
constant) of BACE1 with picein were −5.94 Kcal/Mol and 44.03 µM. Similarly, the binding affinity
and Ki values of gastrodin with BACE1 were −5.78 Kcal/Mol and 57.49 µM (Table 2). The molecular
interaction pattern of both compounds with BACE1 is shown in Figure 3.
Table 2. Binding interaction analysis of gastrodin and picein with BACE1.
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3.4. Mitochondrial Activity (MTT)
The mitochondrial activity was measured to confirm the effect of picein in menadione-exposed
SH-SY5Y cells, where cells were exposed first with menadione (concentrations—1, 10, 15 and 20 µM),
followed by the treatment with a fixed concentration of picein (25 µM). Cells individually treated
with menadione resulted in a statistically significant lower cell viability when compared to the control
cells (Figure 4). Subsequently, follow-up treatment with picein significantly inhibited the effect of
menadione and resulted in a recovery of damaged cells with an increasing concentration of menadione
(MQ). Individually picein-treated SH-SY5Y cells (without MQ), did not show any changes in the level
and was close to the control group.
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Figure 4. Level of mitochondrial activity (MTT) in human SH-SY5Y neuroblastoma cells after menadione
(MQ) treatment and follow-up with picein. The data are presented as mean ± SEM. To give evidence
for the statistical variations, factorial ANOVA was applied to examine the p-values for each factor,
where three experiments with three samples per group were considered. Significant differences were
seen in picein (p = 0.002), and MQ (p < 0.0001). RAU indicates relative absorbance units.
3.5. Reactive Oxygen Species
For the measurements of ROS formation, SH-SY5Y cells were first exposed with menadione
(concentrations—1, 10, 15 and 20 µM), foll wed by the picein treatm nt (25 µM). Cells indivi ually
treated with menadione (without picein) resulted in a stat stically sig ificant incr a e in the ROS
level than in the corresponding control group (Figure 5), although a decre se was d tected at 20 µM
MQ. Afterwards, a significant decrease in the level of ROS was detected in the follow-up treatment
with picein. These results show that picein inhibited the effect of MQ by reducing ROS formation.
No significant changes were seen in SH-SY5Y cells individually treated with picein (without MQ).
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Figure 5. Reactive oxygen species level in human SH-SY5Y neuroblastoma cells were measured after
menadione (MQ) treatment and follow-up treatment with picein. The data are presented as mean± SEM.
To give evidence for the statistical variations, factorial ANOVA was applied to exa ine the p-values
for each factor, where t ree experiments with three samples per group were considere . Statistically
significant differences were examined for picein (p < 0.0001) and MQ (p < 0.0001). RFU indicates
relative fluorescence units.
3.6. Mitochondrial Superoxide Production
The antioxidative effect of picein in menadi e-exposed SH-SY5Y cells as also examined to
observe the mitochondrial superoxide production, where cells were exposed first with menadione
(concentrations—1, 10, 15 and 20 µM), followed by the treatment with picein (25 µM). A statistically
significant increase in the mitochondrial superoxide level (particularly at 20 µM MQ concentration)
was measured in the cells individually treated with m nadione (wi hout pice n) in corresponding
concentrations to the control group (Figure 6). Subsequently, a significant decline in the mitochondrial
superoxide level was also observed in the follow-up treatment with picein, showing the damaged cell
retrieval effect with increasing concentrations of menadione (MQ). No significant changes were seen in
SH-SY5Y cells individually treated with picein (without MQ).
3.7. Live Cell Imaging
The live cell imaging of SH-SY5Y neuroblastoma cells was performed to visually verify the
neuroprotective effects of picein. Microscopy with Mitotracker orange (stains mitochondria in live
cells) was performed with control, menadione-treated (10 µM) and picein-treated (25 µM) samples
after menadione exposure. The live cell imaging of SH-SY5Y cells after menadione exposure showed low
emission of Mitotracker fluorescence, could be indicating an overproduction of ROS, as also reported
by Tomkova et al. [45]. Moreover, the qualitative observations from Figure 7 clearly reveal that the
menadione-exposed cells were morphologically distinct with structural abnormalities, and such deviations
could be interpreted as mitochondrial dysfunction, as has been reported by other researchers [46,47].
However, the follow-up treatment with picein of menadione-stressed cells showed an increase in
fluorescence intensity of Mitotracker, suggesting a decrease in ROS production with an increase in
mitochondrial membrane potential (Figure 7). Consequently, these results showed that picein may lead
to a significant recovery of damaged cells with a comparable morphology similar to that of untreated
control cells.
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4. Discussion
In this study, human SH-SY5Y neuroblastoma cells were used to study the oxidative stress
responses of menadione with the subsequent neuroprotective effect of picein. In addition to live cell
imaging, ROS and mitochondrial superoxide production were observed along with mitochondrial
activity, as these parameters are consistent with the suspected adverse response to menadione by
human neuroblastoma cells. Thus, this study aimed to monitor the oxidative stress levels in SH-SY5Y
cells and further the stress inhibitory role of picein in a follow-up treatment. The hypothetical
concept of the present study was developed from our recent publication Dou et al. [18], where picein
was extracted from willow bark (Salix sp.) and further medicinal applications were analyzed by
a computational approach. Picein is a mispriced and cryptic compound in the scientific domain,
on which any neurological study has not yet been published to the best of our knowledge. Therefore,
this study explores the basic chemical (in silico) and biological properties of picein to identify its
putative role in the list of natural and bioactive compounds.
Primarily, the chemical structure similarity search was performed to identify the closest analogue
of picein and to predict its putative biological activity. Gastrodin is the closest analogue of picein,
for which a 0.92 similarity score out of 1 was obtained after a computational approach (Table 1).
Gastrodin has been identified as a natural bioactive compound of Rhizoma Gastrodia, a dried rhizome
of Gastrodia elata Blume (G. elata), tested as a popular Chinese herb for the treatment of epilepsy,
stoke, spasm, and dizziness and headache [48]. The studies of Feng et al. [49] and Zhou et al. [50]
have reported that the gastrodin isolated from G. elata has promising pharmacological properties.
Since then, this compound has been recognized as a proven sedative, hypnotic, antivertigo, antiepileptic,
antidepressant, anxiolytic, and memory-improving agent [30]. Several other studies also reported
that gastrodin (5000 research articles) is actively being investigated for its role in the treatment of
neurological diseases [31–33], Alzheimer’s disease [34–36] and depression [37,38].
Based on the similarity scores and pharmacological properties of gastrodin [51], picein is considered
as a neuroprotective compound. Additionally, Lipinski’s rule of five was also analyzed from a
computational approach to affirm the drug-likeness of both compounds regarding their antioxidative
capacity (Figure 3). Thus, this study mainly focusses on the role of picein in neuroprotection. From here,
this study led toward targeting the identification step, where the PharmMapper web-server was used
to screen out the probable biomolecular targets of both compounds. Interestingly, by the reverse
docking approach, beta-secretase 1 (BACE-1) was found as the best biomolecular target for both
compounds (Figure 4). These results confirm the chemical and biological similarity between both of the
query compounds. In beta-secretase 1, the beta-site APP-cleaving enzyme is an aspartic-acid protease,
which has great importance for the myelin sheath development in peripheral nerve cells [52]. However,
its over-activation may lead to the genesis and cleavage of APP (amyloid-beta precursor protein), which
has been recognized as a key biomarker for the progression of neurodegenerative diseases like AD [52].
For the cross-validation of the relation between BACE1 and APP, we have performed the network
topological and protein-protein interaction analysis and found the strong relationship between BACE-1
and APP (Figure 3). Network topological analysis shows that the clustering coefficient of BACE1 was
0.19. However, if the clustering coefficient (Pearson correlation coefficient) is found to be less than
0.5, it could be simulated to bind a distinct ally at particular time points and restricted to date hubs.
These date proteins are important in PIN, but hold a lower number of connections. Therefore, chances
of the binding of drug or other ligands would be higher than party proteins (party proteins, co-efficient
more than 0.5 and show a high degree of co-expression with interaction nodes/partner were assumed to
interact at the same time with their interaction nodes/partners) [53]. However, betweenness centrality
was 128.33, and higher betweenness controls most of the data flow in the network, which may represent
the critical points of the network [54]. Hence, these topological parameters strongly support BACE1
as a suitable drug target of picein and gastrodin (Figure 3). Molecular docking studies also helped
us to find out the preferential binding capability of both compounds with BACE1, where picein has
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found better binding ability towards BACE1 than gastrodin. The biocomputational results narrate our
hypothesis that picein behaves as a better neuroprotectant than gastrodin.
For the implementation of biocomputational findings, cell culture-related endpoints were performed
to justify the proposed hypothesis and mechanism of picein for the treatment of neurodegenerative
diseases. The experiments were directed to confirm the effects of picein, and the expected responses
were detected, where a decreased ROS level was measured in the picein-treated cells compared to the
menadione-treated cells (Figure 1). Moreover, treatment with picein blocked the effect of menadione
and resulting in a decreased ROS level close to the control cells. A systematically increasing trend
in the ROS level was observed after individual treatment of menadione, where it was higher at 1, 10
and 15 µM and decreased at a 20 µM concentration (Figure 5). The decrease in the ROS level at higher
concentrations was obvious, due to lower and under-stressed cell conditions. Similarly, Kang et al. [55]
also investigated the enhanced level of ROS after short menadione exposures on neuroblastoma
cells, while longer treatment resulted in a lowering of the ROS level. This was also confirmed by
mitochondrial activity, where cells were stressed with increasing concentrations of menadione. Picein
at a fixed concentration of 25 µM significantly blocked the menadione effects on cells by inhibiting the
cells with oxidative damage (Figure 4). MTT is a well-known assay for the detection of compounds that
interfere with or produce alterations in mitochondrial activity [56]. However, in living cells, mitochondria
turn yellow MTT to purple formazan, and this could be because of live cells reacting with tetrazolium
salts as active mitochondrial dehydrogenase enzymes, cleaving the tetrazolium ring [57,58].
Menadione produces intracellular ROS over futile redox cycling at multiple cellular sites, which
also depends on the concentrations. Consequently, menadione-conciliated oxidant responses at lower
concentrations may activate redox-dependent gene expression [59]. However, menadione-induced
oxidative stress at higher concentrations is linked with the cellular injury and cell death [59–62].
The present study is in agreement with our previous work, where Kesari et al. [44,63] also reported that
the menadione-induced oxidative stress increases the ROS level in addition to mitochondrial superoxide
production in SH-SY5Y cells. Thus, the mitochondria-specific probe MitoSOX Red was employed to
detect the superoxide production and to assess the integrity of mitochondria [64,65]. Several recent
studies reported that the ROS formation in mitochondria may lead to mitochondrial superoxide
production [44,66,67]. In this study, menadione treatment increases mitochondrial superoxide
production after exposure to the increasing trend (Figure 6). Thereafter, treatment with picein
was found to block the menadione effect and the level of superoxide was kept close to the control cells.
MitoSOX red, a novel fluorogenic probe, can bind to the nuclear DNA and therefore identify superoxide
in the live cells of mitochondria [64]. In addition to this, the selective mitochondrial probe Mitotracker
orange was employed in this study, which is highly receptive to mitochondrial membrane potential
and considered a sensitive indicator for the measurement of oxidative stress in mitochondria [45].
The accumulation of Mitotracker in cells mainly depends on the mitochondrial membrane potential [68]
because it disseminates throughout the plasma membrane and accumulates in live mitochondria.
Figure 7 shows a decreased Mitotracker fluorescence intensity in the menadione-treated group as
compared to control and picein-treated groups. Lower Mitotracker fluorescence results in ROS
production and could be acknowledged as the reliable assay to examine the oxidative stress even at
low-level ROS formed in mitochondria. Kweon et al. [69] reported that the intracellular superoxide
production can be detected by Mitotracker at the early phase and later may be converted to H2O2.
The proposed mechanism of picein for blocking the effect of menadione has been presented in Figure 1.
The data of this study, therefore, highlight the importance of advances in drug discovery methods by
undertaking several highly specified molecular biology and computational parameters.
5. Conclusions
The findings of the present study mainly conclude the statistically significant decrease in ROS
levels and superoxide production after treatment with picein, indicating its neuroprotective properties.
Additionally, mitochondrial activity (MTT) showed significant recovery of cells after picein treatment,
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which indicates the inhibition of mitochondrial ROS formation. Moreover, live cell imaging was
employed as an indicator of mitochondrial oxidative stress, where low absorption of Mitotracker
fluorescence indicated an overproduction of ROS. In silico modeling of the molecular structure of
picein resulted in a surprising similarity of 92% with gastrodin. Although gastrodin is well-known
for its role in neuroprotection, picein was found to possess better neuroprotective properties than
gastrodin. Picein as a neuroprotectant has great possibilities towards drug formulation first with
animal model experiments. However, based on the present study and in vitro model, picein could be
used in transgenic APP/PS1 mice (AD animal model) for the treatment of neurodegenerative diseases
for future research. We have also identified a novel BACE1 inhibitor, picein, which acts as a strong
neuroprotectant and has therapeutic potential for AD treatment. The overview of the whole study is
presented in Figure 1.
Consequently, the present study confirms the antioxidative property of picein against the
oxidative stress induced by menadione in human neuroblastoma cells. Therefore, this study lays a
great foundation to further explore the development of drugs for neurodegenerative diseases based on
picein, along with the other extracted compounds of a single clone willow hybrid Karin. The extract
composition of compounds varies greatly between the hundreds of individual willow hybrids that
have been developed so far. So, in the future, there are great possibilities to progress in different areas
of research where the biological activity of the extracts is important.
Author Contributions: K.K.K., A.D. planned, designed, and performed the experiments. S.S., N.P., A.S., J.D.
helped in experiments. J.R., T.V. and J.M.R. supervised the work. All authors contributed in writing and editing of
the manuscript. All authors have read and agreed to the published version of the manuscript.
Funding: This research was funded by Academy of Finland, grant number 290324 (JR), 309374 (JMR) and the
APC was funded by 290324 (JR).
Acknowledgments: Authors are thankfully acknowledged Mauri Kostiainen, Department of Bioproducts and
Biosystems, Aalto University, Espoo, Finland for his help in providing laboratory facility and resources.




APP Amyloid-beta precursor protein
BACE-1 Beta secretase enzyme
CHIPPI CHimeric protein-protein interaction server
DNA Deoxyribonucleic acid
DMEM Dulbecco’s modified Eaglés medium
DMSO Dimethyl sulfoxide
DCFH-DA 2′,7′-dichlorofluorescein diacetate
PBS Phosphate buffer saline
FBS Foetal bovine serum
HPLC High performance liquid chromatography
KEGG Kyoto encyclopedia of genes and genomes
MTT Thiazolyl blue tetrazolium bromide
MQ Menadione




RFU Relative fluorescence units
RAU Relative absorbance units
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ROS Reactive oxygen species
SH-SY5Y Neuroblastoma cell
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